• OFID 2017:4 (Suppl 1) • Poster Abstracts identified in 163 patients (65%). Clindamycin resistance was identified in 21 cases (8%). Median length of SAB was 3 days (IQR 2-4). In twenty-six patients (11%) SAB lasted 7 or more days. In bivariate analysis, pneumonia (OR 4.6, 95% CI 2-10.6, P < 0.001), sepsis at admission p 0.002), intensive care unit admission (OR 2.9 95% CI 1.3-7, P < 0.01), delayed drainage (OR 4.7, 95% CI 1.4-16, p: 0.01) and MRSA (OR 7.4, 95% CI 1.7-31, p 0.01) were associated with prolonged SAB. No association with age, sex, site of infection, Vancomycin or Clindamycin empiric treatment was found. In multivariate logistic model, MRSA (OR 5.9 95% CI 1.4-25.9 p: 0.02) and sepsis at admission day (OR 2.9, 95% CI 1.3-2.5, p: 0.01) were predictors of SAB duration more than 7 days.
Background.
Little is known about the bacterial communities in the nares of critically ill neonates. Our objectives were to explore the evolving nasal microbiome in neonates who acquire Staphylococcus aureus (S. aureus) colonization and the impact of intranasal mupirocin on the nasal microbiome.
Methods. In the setting of a tertiary care neonatal intensive care unit S. aureus control program where neonates are screened weekly using chromogenic agar cultures and treated with intranasal mupirocin if found to acquire S. aureus colonization, we identified 15 neonates, 8 who acquired S. aureus colonization (cases) and 7 who did not acquire S. aureus colonization (controls). Cases and controls were matched on chronologic age and systemic antibiotic exposure. DNA was extracted for amplification of the 16S rRNA gene (V3V4 region), followed by next-generation sequencing using Illumina MiSeq. Sequences were merged into consensus fragments by FLASH and submitted for high-resolution taxonomic assignment using Resphera Insight. Differentially abundant taxa and alpha diversity measures were detected utilizing a nonparametric difference test with p-value correction using the False Discovery Rate.
Results. Compared with conventional bacterial culture results, sequencing identified S. aureus membership in residual culture samples of all neonates who acquired S. aureus colonization. Figure 1 illustrates statistically significant differences in abundant taxa comparing cases prior to S. aureus colonization and controls. Several species were more abundant in controls, including Corynebacterium propinquum and accolens and Rothia mucilaginosa. C. propinquum and accolens and Rothia mucilaginosa were also more abundant in neonates after treatment with intranasal mupirocin than before treatment.
Conclusion. These data suggest that there are differences in bacterial taxa abundance in the nasal microbiome in neonates who do and do not acquire S. aureus colonization and in neonates before and after treatment with intranasal mupirocin. A single species may not provide sufficient resistance to S. aureus colonization, but a community of organisms may protect against colonization. 
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Background.
A cluster of invasive disease caused by group A Streptococcus (GAS) was detected among children admitted to Nationwide Children's Hospital (NCH) in Columbus, Ohio. Clinical characteristics and molecular epidemiology of this cluster were studied to find out whether the observed cases were caused by closely related GAS strains.
Methods. Patient electronic medical records were reviewed for demographic, epidemiologic and clinical data. Cases were defined as patients with GAS isolated from a normally sterile site, or from a non-sterile site in combination with clinical signs of severe streptococcal illness. Susceptibility testing (E-test), analysis of the GAS emm types, multilocus sequence typing (MLST) and pulse field gel electrophoresis (PFGE) from isolates were performed.
Results. Thirteen children were admitted to NCH with invasive GAS disease between February 19 and March 23, 2017, from seven different Ohio counties (total population of approximately 1.8 million). The spectrum of illness was broad, including STSS (3 patients), GAS sepsis (3), orbital cellulitis with epidural abscess (3), bacteremia and subdural empyema (2), peritonsillar abscess (1), and septic arthritis (1). One patient with STSS died. Only two patients had chronic illnesses. One patient was diagnosed with acute myeloid leukemia on admission. Median age was eight years (range 0.1-16 years). Of six patients with STSS and sepsis only one received clindamycin and four were given IVIG. Hypocalcemia (67%) was common. Isolates from 12 patients were available for emm gene analysis and belonged to nine different emm types: 1, 2, 3, 6, 12, 22, 89, 118, 227 . Two emm 1 and one emm 227 isolates had the same PFGE pattern. All isolates were susceptible to macrolides.
Conclusion. In a population of 1.8 million, 13 pediatric patients with invasive GAS disease during a five-week period represented an apparent outbreak with polyclonal GAS isolates. There was no reported epidemiologic association among the patients and the outbreak was not preventable. A proposed 30-valent M-protein vaccine would have provided protection against 93% of outbreak isolates.
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